pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
globenewswire health·Jul 24·1 min read
save

Vaisala Oyj discloses executive Girish Agarwal receiving 1,000 shares at no cost

Jul 24, 2026·read at globenewswire health ↗RegulatoryNeutral

Vaisala Oyj, a Finnish climate‑measurement technology company listed on Nasdaq Helsinki, filed a regulatory notice on 23 July 2026 regarding an insider transaction.

The notice identifies Girish Agarwal, a member of the senior management team, as the recipient of 1,000 ordinary shares of Vaisala (ISIN FI0009900682). The transaction is recorded as a share receipt with a unit price of €0.00, indicating the shares were transferred at no cost.

The filing, required under Finnish market regulations, provides the transaction details and a contact for investor relations. No other material information about the company’s operations or financial performance was disclosed.

source

This writeup was produced by pharmadog from original reporting by globenewswire health.

Original headline: “Vaisala Oyj: Johtohenkilöiden liiketoimet – Agarwal, Girish”

read at globenewswire health ↗
118 words · retrieved Jul 29
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • Aug 10Aspo Oyj - Johdon liiketoimetglobenewswire health
  • Aug 10Aspo Plc - Managers' Transactionsglobenewswire health
  • Aug 7Ledende medarbejder transaktionglobenewswire health
  • Aug 7Ledende medarbejders køb af aktierglobenewswire health
  • Aug 6Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officerglobenewswire health